NCT04767035View on ClinicalTrials.gov

Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 14, 2021

Study Completion Date

January 14, 2021

Conditions
Procedural Sedation
Interventions
DRUG

midazolam / ketamine sublingual tablet

sublingual tablet

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Collaborators (1)

Worldwide Clinical Trials
All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

Melt Pharmaceuticals

INDUSTRY